Towards Healthcare
Cell and Gene Therapy Isolator Market to Rise USD 4.47 Bn by 2034

Cell and Gene Therapy Isolator Market Sees Surge in Innovation

Market insights predict the global cell and gene therapy isolator industry will increase from USD 1.35 billion in 2024 to USD 4.47 billion by 2034, achieving a CAGR of 12.54%. The growing demand for cell and gene therapy products and technological advancements drive the market. North America dominated the global market due to the presence of key players and the availability of state-of-the-art research and development facilities.

Content

  • Insight Code: 6083
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The cell and gene therapy isolator market stands at USD 1.52 billion in 2025 and is expected to reach USD 4.47 billion by 2034, growing at a CAGR of 12.54% from 2024 to 2034.

North America is leading the cell and gene therapy isolator market due to the availability of state-of-the-art research and development facilities, the presence of key players, and favorable regulatory support.

The cell and gene therapy isolator market includes 5 segments by application, by therapeutic area, by technology type of isolator, by end-user, and by region.

Some key players include Getinge AB, BioSpherix, and Carlo Erba Group.

Key trends include the growing demand for cell and gene therapy, increasing investments, and technological advancements.

Food and Drug Administration, clinicaltrials.gov, Alzheimer Association, Press Information Bureau
Any Questions